GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Capex-to-Revenue

Vicplas International (SGX:569) Capex-to-Revenue : 0.11 (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Vicplas International's Capital Expenditure for the six months ended in Jan. 2024 was S$-5.78 Mil. Its Revenue for the six months ended in Jan. 2024 was S$51.06 Mil.

Hence, Vicplas International's Capex-to-Revenue for the six months ended in Jan. 2024 was 0.11.


Vicplas International Capex-to-Revenue Historical Data

The historical data trend for Vicplas International's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Capex-to-Revenue Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.08 0.05 0.10 0.04

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.10 0.04 0.04 0.11

Competitive Comparison of Vicplas International's Capex-to-Revenue

For the Medical Devices subindustry, Vicplas International's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicplas International's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vicplas International's Capex-to-Revenue falls into.



Vicplas International Capex-to-Revenue Calculation

Vicplas International's Capex-to-Revenue for the fiscal year that ended in Jul. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-5.346) / 129.216
=0.04

Vicplas International's Capex-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-5.783) / 51.057
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicplas International  (SGX:569) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Vicplas International Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vicplas International's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines